ERYTHROCIN I.V.

This brand name is authorized in Canada, Malta, New Zealand

Active ingredients

The drug ERYTHROCIN I.V. contains one active pharmaceutical ingredient (API):

1 Erythromycin
UNII 33H58I7GLQ - ERYTHROMYCIN LACTOBIONATE

Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.

Read about Erythromycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J01FA01 Erythromycin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 00682268, 00682276
Country: MT Medicines Authority Identifier(s): AA565/11206, AA565/11207
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 274

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.